This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ichigotani, Y. Articles by Matsuda, S. Search for Related Content PubMed PubMed Citation Articles by Ichigotani, Y. Articles by Matsuda, S.

Forced Expression of NESH Suppresses Motility and Metastatic Dissemination of Malignant Cells¹

Department of Molecular Pathogenesis [Y. I., M. H., S. M.], and Second Department of Internal Medicine [S. Y., Y. F.], Nagoya University School of Medicine, Nagoya 466-8550, Japan

To characterize the function of a novel Src homology 3 (SH3) adapter proteintermed NESH, we have established transfectants stably expressing NESH.We observed that every clone of NESH transfectants caused a marked reduction in motility, although the clones exhibited no significant differences in intrinsic cell growth compared with the control cells in vitro. The NESH transfectants also exhibited significant reduction in tumor metastatic potential in vivo. We found that NESH expression is frequently lost in invasive cancer cell lines despite its ubiquitous expression in normal tissues. The SH3 domain of NESH seems to interact with p21-activated kinase (PAK), which is involved in regulation of cell motility. Furthermore, a significant decrease in PAK phosphorylation at ⁴⁰²Thr was found in NESH transfectants. Taken together, these results suggest that NESH inhibits ectopic metastasis of tumor cells as well as cell migration through interaction with intracellular molecules such as PAK that are essential for cell motility.

This article has been cited by other articles:

				F. R M Latini, J. P Hemerly, G. Oler, G. J Riggins, and J. M Cerutti Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion Endocr. Relat. Cancer, September 1, 2008; 15(3): 787 - 799. [Abstract] [Full Text] [PDF]

				S. Kano, N. Miyajima, S. Fukuda, and S. Hatakeyama Tripartite Motif Protein 32 Facilitates Cell Growth and Migration via Degradation of Abl-Interactor 2 Cancer Res., July 15, 2008; 68(14): 5572 - 5580. [Abstract] [Full Text] [PDF]

				S. Matsuda, S. Yokozaki, H. Yoshida, Y. Kitagishi, N. Shirafuji, and N. Okumura Insulin receptor substrate protein 53 (IRSp53) as a binding partner of antimetastasis molecule NESH, a member of Abelson interactor protein family Ann. Onc., July 1, 2008; 19(7): 1356 - 1357. [Full Text] [PDF]